This is a rabbit polyclonal antibody against SLC35C1. It was validated on Western Blot by Aviva Systems Biology.
|Immunogen:||The immunogen for anti-SLC35C1 antibody: synthetic 67 directed towards the N terminal of human SLC35C1|
|Reconstitution:||Add 100 µl of distilled water. Final anti-SLC35C1 antibody concentration is 1 mg/ml in PBS buffer.|
|Long Term Storage:||-20°C|
|Miscellaneous/General:||The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X;18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. Chromosome Xp11 contains a segmental duplication resulting in two identical copies of synovial sarcoma, X breakpoint 4, SSX4 and SSX4B, in tail-to-tail orientation. This gene, SSX4B, represents the more centromeric copy. Two transcript variants encoding distinct isoforms have been identified for this gene.|
|Background / Technical Information:||http://www.uniprot.org/uniprot/O60224||